John Presser is the founder of Mezzion. Mezzion has raised $40M in total funding. Latest round: Series C. Based in Seoul, South Korea.
John Presser is an executive at Mezzion, where he serves as EVP, Chief Business Officer and a board member. He was involved in the company's $20 million strategic funding round to advance global Phase 3 development of udenafil for Fontan circulation patients.
Full founder directory · Investor directory · Company funding database · Fundraising library